Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.
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Introduction
Although the formation of fluid-filled cavities is a common feature of human spinal cord injury (SCI), not all human SCI leads to cavity formation. In fact, connective tissue scars characterized by accumulation of collagen, fibronectin, and fibroblasts dominate the injury sites in massive compression and laceration SCI cases (Bunge et al., 1997; Kim, 2013) . In these cases, a surprisingly small glial response and no cavity formation are observed (Bunge et al., 1997; Kim, 2013) . These findings suggest that fibrotic scarring may be an impediment to tissue repair and axonal regeneration after severe compression and laceration spinal cord injuries in humans. In the present study, we examined fibrotic responses after SCI using a severe mouse contusion model, which compresses the spinal cord for a prolonged period of time and results in significant fibrotic scarring (Jeong et al., 2017) .
Fibrotic scar formation is mediated by the assembly of a fibronectin matrix through a stepwise cell-mediated process (Erickson et al., 1981; Allio and McKeown-Longo, 1988; Fogerty et al., 1990; Aguirre et al., 1994) . Fibronectin is composed of multiple repeated domains: twelve type I domains, two type II domains, and fifteen type III domains (Erickson et al., 1981; Erickson and Carrell, 1983; Rocco et al., 1987; Fogerty et al., 1990; Johnson et al., 1999) . Type III domains contain two alternatively spliced domains: extra domain A (EDA) and extra domain B (EDB). Hepatocytes in the liver produce plasma fibronectin that lacks both EDA and EDB (Tressel et al., 1991; Wilson and Schwarzbauer, 1992; Magnusson and Mosher, 1998) . By contrast, cellular fibronectin is synthesized by fibroblasts, endothelial cells, and myoblasts and undergoes alternative splicing to include EDA (FnEDA) and/or EDB domains (FnEDB) (Mao and Schwarzbauer, 2005) .
In particular, the FnEDA splice variant has been implicated in pathological fibrosis in models of skin wound healing, idiopathic pulmonary fibrosis and scleroderma (Muro et al., 2003; Muro et al., 2008; Bhattacharyya et al., 2014) . FnEDA is virtually absent from normal adult tissues, and uninjured mice lacking FnEDA are indistinguishable from wildtype mice (Manabe et al., 1997; Shiozawa et al., 2001; Muro et al., 2003; Muro et al., 2008; Khan et al., 2012; Bhattacharyya et al., 2014) . However, FnEDA-null mice demonstrate abnormal skin wound healing, ulceration, and inflammation at sites of injury (Muro et al., 
